The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Our cutting-edge technology and internal R&D resources enable us to provide all-inclusive solutions, pioneering, reliable and easy-to-use. By intervening well upstream of its customers’ requirements and by anticipating the technical, environmental and regulatory changes, Technoflex optimize the design of the future generations of flexible bags and associated connectors. Our proficiency of the manufacturing process in clean room ISO7 (Class 10000) allows us to provide innovative containers with a low AQL. The different ranges of bags, Inerta®, Biocell®, Cryocell®, SafeCell®, Dual-Mix®, ReadyMix®, developed by Technoflex are designed for various application such as: Cell therapies, Biotherapies, IV therapies, Compounding, Animal Health. All our bags are compliant with the European and American pharmacopoeias (FDA: DMF #19057 and Canada DMF # 2007-070)
For more information, please visit: www.technoflex.net